Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Lancet. Oncology

Showing results (1-10 of 3,329) with videos related to

Pageof 333
Sort By:
The Lancet. Oncology|July 10, 2003
Prostate cancer: a dynamic illness with shifting targetsDavid R Shaffer, Howard I Scher
The Lancet. Oncology|July 10, 2003
Why did p53 gene therapy fail in ovarian cancer?Alain G Zeimet, Christian Marth
The Lancet. Oncology|July 10, 2003
Current uses of isolated limb perfusion in the clinic and a model system for new strategiesAlexander M M Eggermont, Johannes H W de Wilt, Timo L M ten Hagen
The Lancet. Oncology|August 7, 2003
The role of surgery in the management of oesophageal cancerPeter C Wu, Mitchell C Posner
The Lancet. Oncology|September 11, 2003
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growthCecilia Sgadari, Paolo Monini, Giovanni Barillari, et al.
The Lancet. Oncology|September 11, 2003
Bacteria as tumour-targeting vectorsJohn M Pawelek, K Brooks Low, David Bermudes
The Lancet. Oncology|September 11, 2003
New insights into the pathophysiology of multiple myelomaSonja Seidl, Hannes Kaufmann, Johannes Drach
The Lancet. Oncology|February 11, 2011
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 studyHedy L Kindler, Tatsuya Ioka, Dirk J Richel, et al.
The Lancet. Oncology|February 8, 2011
Definition and classification of cancer cachexia: an international consensusKenneth Fearon, Florian Strasser, Stefan D Anker, et al.
The Lancet. Oncology|November 25, 2010
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
Pageof 333

Showing results (1-10 of 3,329) with videos related to

Sort By:
Pageof 333
The Lancet. Oncology|July 10, 2003
Prostate cancer: a dynamic illness with shifting targetsDavid R Shaffer, Howard I Scher
The Lancet. Oncology|July 10, 2003
Why did p53 gene therapy fail in ovarian cancer?Alain G Zeimet, Christian Marth
The Lancet. Oncology|July 10, 2003
Current uses of isolated limb perfusion in the clinic and a model system for new strategiesAlexander M M Eggermont, Johannes H W de Wilt, Timo L M ten Hagen
The Lancet. Oncology|August 7, 2003
The role of surgery in the management of oesophageal cancerPeter C Wu, Mitchell C Posner
The Lancet. Oncology|September 11, 2003
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growthCecilia Sgadari, Paolo Monini, Giovanni Barillari, et al.
The Lancet. Oncology|September 11, 2003
Bacteria as tumour-targeting vectorsJohn M Pawelek, K Brooks Low, David Bermudes
The Lancet. Oncology|September 11, 2003
New insights into the pathophysiology of multiple myelomaSonja Seidl, Hannes Kaufmann, Johannes Drach
The Lancet. Oncology|February 11, 2011
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 studyHedy L Kindler, Tatsuya Ioka, Dirk J Richel, et al.
The Lancet. Oncology|February 8, 2011
Definition and classification of cancer cachexia: an international consensusKenneth Fearon, Florian Strasser, Stefan D Anker, et al.
The Lancet. Oncology|November 25, 2010
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
Pageof 333